BioNTech SE’s founders will leave the company to start a new biotech focused on messenger RNA, the technology behind their ...
BioNTech's co-founders, Ugur Sahin and Oezlem Tuereci, plan to leave by year's end to start a new venture, causing BioNTech's shares to plummet. The couple aims to focus on mRNA-based drugs at an ...
BioNTech SE’s founders will leave the company to start a new biotech focused on messenger RNA, the technology behind their ...
Right before BioNTech was due to announce its 2025 results, the company’s co‑founders, Ugur Sahin and Özlem Türeci, revealed they would leave the company to focus on develop ...
In January last year, German biotech company BioNTech acquired African AI startup InstaDeep for over $550 million, a deal finalized in July of the same year. InstaDeep, whose exit is currently the ...
BioNTech reported Q1 revenue of $192.23 million, surpassing the consensus of $177.40 million. Cash and investments totaled 15.85 billion euros as of March 31, 2025. Geopolitical tensions, Fed ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results